Provider of a data insights platform intended to accelerate healthcare innovation and optimize drug and device development. The company's platform utilizes regulatory-grade data sets to uncover new market opportunities, enhance trial design and enrollment, gain competitive intelligence to benchmark commercial success, target marketing efforts, among others, enabling life science companies to make informed decisions using data from clinical specialty database.
Generating Revenue
Privately Held (backing)
Venture Capital-Backed
The company raised $30 million of Series C venture funding in a deal led by GV on July 31, 2018, putting the company's pre-money valuation at $15 million. GE Ventures, Biomatics Capital, Lagunita BioSciences and Brook Byers also participated in the round. The company will use the funding to continue building its medical informatics and technology team and to expand its platform.
Add a review